Ceftaroline-Associated Neutropenia: Case Series and Literature Review of Incidence, Risk Factors, and Outcomes

Ceftaroline is increasingly prescribed for “off-label” indications involving longer durations and higher doses. There have been postmarketing case reports of neutropenia among patients who have received extended durations of ceftaroline, but limited published data currently exist on its incidence an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Eva L, Turner, R Brigg, O’Neal, Hollis R, Crum-Cianflone, Nancy F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524829/
https://www.ncbi.nlm.nih.gov/pubmed/31123688
http://dx.doi.org/10.1093/ofid/ofz168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524829/
https://www.ncbi.nlm.nih.gov/pubmed/31123688
http://dx.doi.org/10.1093/ofid/ofz168

Ejemplares similares